Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac

Background. A meningococcal group A conjugate vaccine, PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and manufactured by the Serum Institute of India, Ltd, was tested in multiple clinical trials conducted mainly in Africa. The impact of age at which subjects were vaccinated o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Tang, Yuxiao, Plikaytis, Brian D., Preziosi, Marie-Pierre, Borrow, Ray
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639503/
https://ncbi.nlm.nih.gov/pubmed/26553685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ601
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars